UK business unaware of US corruption laws

UK businesses are largely unaware of the risks they might face when doing business in the US despite the NatWest Three publicity

Written by AccountancyAge.com

A new survey by KPMG Forensic reveals 46% of legal department heads at FTSE350 companies which conduct business in the US either wrongly believe they are immune from US prosecutors or are simply unaware whether they might fall under their jurisdiction.

KMPG surveyed general counsels and company secretaries at FTSE350 companies on their awareness of the US Foreign and Corrupt Practices Act (FCPA), legislation which permits US authorities prosecute foreign companies and individuals with a ‘US footprint’ for corrupt practices involving public officials.

Advertisement

Under the act, UK companies leave a US footprint if they do business in the country or if they use American financial institutions as advisers.

'The lack of awareness by companies of the scope of US anti-corruption laws is especially concerning,' Jennifer Hammond, a director at KPMG Forensic, said. 'The US regulators take an uncompromising approach to this issue, and have carried out an increasing number of investigations since 2001.'

Further reading:

NatWest Three given £3.5m payback reprieve

Tags:

Comments

White papers

Related jobs

More Accounting jobs

Spotlight

Ted Bell, Abel and Cole FD

Profile: Ted Bell, FD of Abel and Cole

The combination of the online shopping boom and a hunger...

Top 30 Accounting Networks and Associations 2008

The race to become the biggest firm on the planet...

Barack Obama Accountancy Age cover October 2008

Obama: asset or liability?

What an Obama presidency could mean for you

Find your next job

Find your next job
Salary Checker

Job of the week

More finance jobs

Newsletters

Sign up here for the very latest news delivered to your inbox. Choose from the following options:

Your next job

Have your say

Will proposed tax cuts help to stimulate the economy?
Yes
No

Advertisement

Search white papers

Search white papers

Advertisement